Vicarious Surgical (RBOTW) Shares Outstanding (Weighted Average) (2020 - 2025)
Vicarious Surgical (RBOTW) reported Shares Outstanding (Weighted Average) of $27.6 million for Q4 2025, little changed year-over-year from $27.6 million in Q4 2024, and little changed quarter-over-quarter from $27.6 million in Q3 2025.
Vicarious Surgical (RBOTW) Shares Outstanding (Weighted Average) (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $27.6 million in Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $27.6 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $27.6 million (changed 0.0% YoY), and the FY2025 annual result was $27.6 million, changed 0.0% from the prior year.
- Shares Outstanding (Weighted Average) steadied at $27.6 million in Q4 2025 per RBOTW's latest filing, from $27.6 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $126.1 million in Q1 2023 and troughed at $4.2 million in Q2 2023.
- A 5-year average of $50.7 million and a median of $27.6 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) jumped 1294.55% in 2022, then tumbled 96.51% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $96.7 million in 2021, then increased by 25.96% to $121.8 million in 2022, then plunged by 77.3% to $27.6 million in 2023, then changed by 0.0% to $27.6 million in 2024, then changed by 0.0% to $27.6 million in 2025.
- Business Quant data shows RBOTW's Shares Outstanding (Weighted Average) at $27.6 million in Q4 2025, $27.6 million in Q3 2025, and $27.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Vicarious Surgical | - | - | - | 27.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.65 Mn |
| Sep 30, 2025 | 27.65 Mn |
| Jun 30, 2025 | 27.65 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Dec 31, 2024 | 27.65 Mn |
| Sep 30, 2024 | 5.88 Mn |
| Jun 30, 2024 | 5.87 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 27.65 Mn |
| Sep 30, 2023 | 5.17 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 126.13 Mn |
| Dec 31, 2022 | 121.79 Mn |
| Sep 30, 2022 | 121.97 Mn |
| Jun 30, 2022 | 120.81 Mn |
| Mar 31, 2022 | 120.28 Mn |
| Dec 31, 2021 | 96.69 Mn |
| Sep 30, 2021 | 92.23 Mn |
| Jun 30, 2021 | 34.50 Mn |
| Mar 31, 2021 | 8.63 Mn |